Franziska Eckardt

Recent publications by Franziska Eckardt

1. Teaching ophthalmic microsurgical skills: conventional microscopy versus heads-up visualizationBMC Medical Education · Mon,
2. High-Dose 8 mg Aflibercept for Neovascular Age-Related Macular Degeneration: Who Is Being Treated with This New Agent?Life · Thu,
3. Extended Real-World Efficacy of Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: 9-Month Follow-Up ResultsJournal of Clinical Medicine · Mon,
4. Efficacy of switching treatment to faricimab in recalcitrant neovascular age related macular degeneration – 6 month results after completion of the loading phaseGraefe s Archive for Clinical and Experimental Ophthalmology · Thu,
5. Real-World Data on Morphological and Functional Responses After Switching to Faricimab in Recalcitrant, Chronic Diabetic Macular EdemaOphthalmology and Therapy · Mon,
6. Deep learning-assisted analysis of biomarker changes after increase of dosing from aflibercept 2 mg to 8 mg in therapy-resistant neovascular age-related macular degenerationBMJ Open Ophthalmology · Thu,
7. Deep learning assisted analysis of biomarker changes in refractory neovascular AMD after switch to faricimabInternational Journal of Retina and Vitreous · Fri,
8. Switching to Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: Initial Real-World Efficacy OutcomesJournal of Clinical Medicine · Thu,
9. Deep-Learning-Assisted Analysis of Early Biomarker Changes in Treatment-Naïve Patients with Neovascular AMD Under Intravitreal FaricimabOphthalmology and Therapy · Tue,
10. Internal Limiting Membrane Peeling in Primary Rhegmatogenous Retinal Detachment: Functional and Morphologic ResultsKlinische Monatsblätter für Augenheilkunde · Sat,